Screener
Biohaven BHVN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | As of March 31, 2026 | As of December 31, 2025 |
|---|---|---|
| Accrued employee compensation and benefits | $4,428 | $16,781 |
| Accrued clinical trial costs | 21,541 | 30,437 |
| Operating lease liabilities - current portion | 5,900 | 5,756 |
| 2025 Additional Consideration True-Up liability | — | 42,710 |
| Other accrued expenses and other current liabilities | 9,784 | 8,607 |
| Accrued expenses and other current liabilities | $41,653 | $104,291 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's operating lease liabilities (current)?
- Biohaven (BHVN) reported operating lease liabilities (current) of $5.9M in Q1 2026.
- How has Biohaven's operating lease liabilities (current) changed year-over-year?
- Biohaven's operating lease liabilities (current) increased by 25.3% year-over-year, from $4.71M to $5.9M.
- What is the long-term trend for Biohaven's operating lease liabilities (current)?
- Over 4 years (2021 to 2025), Biohaven's operating lease liabilities (current) has grown at a 90.3% compound annual growth rate (CAGR), from $439K to $5.76M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Biohaven's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude